Alpha 2.0
Login Register
» Journals » Eur Urol

European Urology

European Urology is a renowned peer-reviewed journal that focuses on all aspects of urology, providing a platform for high-quality research and clinical studies. With a broad scope covering topics like urological oncology, endourology, and male and female urology, it serves as a valuable resource for urologists, researchers, and healthcare professionals worldwide. The journal aims to advance knowledge, promote innovation, and improve patient care in the field of urology.
Details
Abbr. Eur Urol
Start 1975
End Continuing
Frequency Twelve no. a year, 1998-
p-ISSN 0302-2838
e-ISSN 1873-7560
Country Switzerland
Language English
Specialty Urology
Metrics
h-index / Ranks: 312 261
SJR / Ranks: 149 6928
CiteScore / Ranks: 88 42.00
JIF / Ranks: 130 23.4
Recent Articles
1.
Updated Systematic Review and Meta-analysis of Extracorporeal Shock Wave Lithotripsy, Flexible Ureterorenoscopy, and Percutaneous Nephrolithotomy for Lower Pole Renal Stones
MacLennan S, Wiseman O, Smith D, Starr K, Aucott L, Hernandez R, et al.
Eur Urol . 2025 Mar; PMID: 40082136
Lower pole stones (LPSs) frequently cause significant morbidity, necessitating effective intervention strategies. We systematically reviewed the evidence for treatment of LPSs with extracorporeal shock wave lithotripsy (ESWL), flexible ureterorenoscopy (FURS),...
2.
T-cell Engagers in Prostate Cancer
Hage Chehade C, Ozay Z, Ostrowski M, Mercinelli C, Gebrael G, Sayegh N, et al.
Eur Urol . 2025 Mar; PMID: 40074645
Owing to the "cold" tumor immune microenvironment of prostate cancer, immune-targeting agents have shown limited efficacy in patients with advanced prostate cancer, highlighting the need for new therapies with novel...
3.
Re: Tranexamic Acid During Radical Cystectomy: A Randomized Clinical Trial
Zaurito P, Moschini M, Gandaglia G, Briganti A, Montorsi F
Eur Urol . 2025 Mar; PMID: 40074644
No abstract available.
4.
Re: Paolo Gontero, Alison Birtle, Otakar Capoun, et al. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-A Summary of the 2024 Guidelines Update. Eur Urol 2024;86:531-49
Montorsi F, Rosiello G, Gandaglia G, Salonia A, Briganti A
Eur Urol . 2025 Mar; PMID: 40074643
No abstract available.
5.
Reply to Francesco Montorsi, Giuseppe Rosiello, Giorgio Gandaglia, Andrea Salonia and Alberto Briganti's Letter to the Editor re: Paolo Gontero, Alison Birtle, Otakar Capoun, et al. European Association of Urology Guidelines on Non-muscle-invasive...
Gontero P, Soria F
Eur Urol . 2025 Mar; PMID: 40074642
No abstract available.
6.
Re: Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1)
Flammia R, Leonardo C, Simone G
Eur Urol . 2025 Mar; PMID: 40069076
No abstract available.
7.
When Less Is More: The Challenges of Defining Residual Disease Following Neoadjuvant Hormonal Therapy in Prostate Cancer
Devos G, Giesen A, Joniau S
Eur Urol . 2025 Mar; PMID: 40069075
No abstract available.
8.
Re: A Neoantigen Vaccine Generates Antitumour Immunity in Renal Cell Carcinoma
Zhang H, Liu Y, Lin A, Luo P, Wang L, Jiang A
Eur Urol . 2025 Mar; PMID: 40057402
No abstract available.
9.
Re: High Sperm Deoxyribonucleic Acid Fragmentation Index Is Associated with an Increased Risk of Preeclampsia Following Assisted Reproduction Treatment
Adel Dominguez M, Mora Topete A, Cardona Maya W
Eur Urol . 2025 Mar; PMID: 40057401
No abstract available.
10.
Re: Comparative Efficacy and Safety of Ablative Therapies in the Management of Primary Localised Renal Cell Carcinoma: A Systematic Review and Meta-analysis
Zhang H, Luo P, Lin A, Liu Y, Wang L, Jiang A
Eur Urol . 2025 Mar; PMID: 40055031
No abstract available.